Search Results - A. I. Martynov
- Showing 1 - 20 results of 38
- Go to Next Page
-
1
Longterm experience of magnerot administration in patients with mitral valve prolapse by A. I. Martynov, E. V. Akatova
Published 2011-03-01Within 15 years observation 31 patients with prolaps the mitral valve, regularly accepting magnerot, in a dose of 1500 mg a day during all period of observation by 3-month's courses 2 times a year was spent. Features of dynamics of a clinical picture, their interrelation with phenotypic express...
Get full text
Article -
2
Hypertension in pregnancy: controversial issues of national and international guidelines by V. S. Chulkov, A. I. Martynov, V. A. Kokorin
Published 2021-01-01Hypertensive disorders of pregnancy, including pre-existing and gestational hypertension, preeclampsia and eclampsia, complicate up to 10% of pregnancies and represent a significant cause of maternal and perinatal morbidity and mortality. Despite some differences in guidelines, there is consensus th...
Get full text
Article -
3
Rilmenidine treatment in hypertensive patients with cerebrovascular transient ischemic attacks by A. P. Kondrakhin, G. N. Gorokhovskaya, A. I. Martynov
Published 2005-10-01Aim. To assess effectiveness of rilmenidine treatment in arterial hypertensive (AH) patients with cerebrovascular transient ischemic attacks (TIA). Material and methods. The study included 39 patients with Stage I-III AH, combined with TIA: 6 males and 33 females; mean age 47±2.7 years. At baseline...
Get full text
Article -
4
Clinical effectiveness of magnesium orotate in patients with cardiac arrhythmias, arterial hypertension, and mitral valve prolapse by E. V. Akatova, O. P. Nikolin, A. I. Martynov
Published 2009-08-01Aim. To evaluate the effectiveness of magnesium orotate in the patients with cardiac arrhythmias, arterial hypertension (AH), and idiopathic mitral valve prolapse (MVP). Material and methods. The complex examination, dynamic follow-up, and placebo-controlled differentiated treatment were performed...
Get full text
Article -
5
BETAXOLOL IN THE TREATMENT OF ARTERIAL HYPERTENSION IN POLYCYTEMIA VERA by G. N. Gorohovskaya, V. V. Soboleva, A. I. Martynov
Published 2000-12-01Betaxolol in the treatment of arterial hypertension in polycytemia vera.
Get full text
Article -
6
ENDOTHELIAL DYSFUNCTION IN PATIENTS WITH CORONARY HEART DISEASE AND TYPE 2 DIABETES MELLITUS by M. M. Petina, G. N. Gorokhovskaya, A. I. Martynov
Published 2011-04-01Endothelial dysfunction is one of the earliest stages in atherosclerosis development among patients with diabetes mellitus (DM). At the moment, cardiovascular disease (coronary atherosclerosis complications and coronary heart disease, CHD) is the leading cause of disability and mortality in patients...
Get full text
Article -
7
Long-term magnesium orotate therapy in patients with mitral valve prolapse by A. I. Martynov, A. V. Akatova, O. P. Nikolin
Published 2012-06-01Aim. To assess the effectiveness of long-term treatment with magnesium orotate (Magnerot®), as a pathogenetic therapy, in patients with mitral valve prolapse (MVP). Material and methods. In total, 31 MVP patients, administered Magnerot® (1500 mg/d) in three-month courses, twice a year, were followed...
Get full text
Article -
8
A COMPARATIVE ANALYSIS OF HOW VARIOUS CLASSES OF ANTIHYPERTENSIVES INFLUENCE THE REGRESSION OF LEFT VENTRICLE HYPERTROPHY IN THE ELDERLY by A. I. Martynov, O. D. Ostroumova, V. I. Mamayev, S. Y. Gedgafova
Published 2001-06-01A comparative analysis of how various classes of antihypertensives influence the regression of left ventricle hypertrophy in the elderly.
Get full text
Article -
9
Alprazolam therapy effects on quality of life and vegetative dysfunction syndrome in patients with idiopathic mitral valve prolapse by E. V. Akatova, E. D. Sukhanova, O. P. Nikolin, A. I. Martynov
Published 2010-02-01Aim. To assess quality of life (QoL) and severity of vegetative dysfunction syndrome (VDS) in patients with idiopathic mitral valve prolapse (MVP); to evaluate the effects of alprazolam therapy on QoL and VDS. Material and methods. This single-blind, placebo-controlled study included 60 patients wit...
Get full text
Article -
10
TRUE RESISTANCE AND PSEUDORESISTANCE TO ASPIRIN by A. I. Martynov, E. V. Akatova, I. V. Urlayeva, O. P. Nicolin
Published 2015-09-01Low dose aspirin reduces the secondary incidence of myocardial infarction and stroke. Drug resistance to aspirin might result in treatment failure. Despite this concern, no clear definition of aspirin resistance has emerged, and estimates of its incidence have varied remarkably. Researchers from uni...
Get full text
Article -
11
ARTERIAL HYPERTENSION AND THE MOST PREVALENT CARDIOVASCULAR RISK FACTORS (from the XIX Scientific Congress of the International Association of Arterial Hypertension and the XII Eur... by E. Y. Maychuk, O. A. Vasilevitskaya, I. B. Pechenkina, A. I. Martynov
Published 2002-10-01Arterial hypertension and the most prevalent cardiovascular risk factors (from the XIX Scientific Congress of the International Association of Arterial Hypertension and the XII European Congress on Arterial Hypertension).
Get full text
Article -
12
Outpatient Practice of Lipid-Lowering Therapy Prescription (According to the ARGO-3 Study) by M. V. Ezhov, N. M. Akhmedzhanov, T. E. Kolmakova, A. V. Tyurina, A. I. Martynov
Published 2023-05-01Aim. To study the frequency of prescriptions of various types of lipid-lowering therapy and their effectiveness in outpatient clinical practice based on the results of a questionnaire of primary care physicians.Material and methods. The study was performed in 2022 in 75 constituent entities of the R...
Get full text
Article -
13
ARTERIAL HYPERTENSION ASSOCIATED WITH METABOLIC SYNDROME: FOCUS ON DAILY PROFILES OF CENTRAL AORTIC PRESSURE AND VASCULAR STIFFNESS by L. A. Panchenkova, L. A. Andreeva, K. A. Khamidova, T. E. Yurkova, A. I. Martynov
Published 2016-09-01Purpose: to evaluate the parameters of the central aortic pressure and arterial stiffness during the day in patients with arterial hypertension (AH) with metabolic syndrome (MS) Material and methods: The study included 48 subjects divided into 2 groups: 23 (47,9%) subjects with AH, 25 (52,1%) subjec...
Get full text
Article -
14
Endothelial dysfunction and methods for its diagnostics by A. I. Martynov, N. G. Avetyak, E. V. Akatova, G. N. Gorokhovskaya, G. A. Romanovskaya
Published 2005-08-01.
Get full text
Article -
15
ADVANCED USE OF COENZYME Q10 IN PATIENTS WITH CARDIOVASCULAR DISEASES by A. I. Martynov, G. N. Gorohovskaya, V. L. Yun, A. A. Barvinskiy, M. M. Petina
Published 2013-03-01This report examines interest in compounds that normally prevent the toxic effects of ROS -antioxidants, namely reduced ubiquinone, which is only lipid soluble antioxidant synthesized in cells of animals and humans, and continuously recovered from oxidized form by enzyme systems of the body, to poss...
Get full text
Article -
16
CLINICAL EFFECTIVENESS OF EARLY ACUTE MYOCARDIAL INFARCTION DIAGNOSTICS, BASED ON THE ASSESSMENT OF CARDIAC FATTY ACID BINDING PROTEIN LEVELS by A. I. Martynov, M. I. Voevoda, G. P. Arutyunov, V. A. Kokorin, A. A. Spasskyi
Published 2012-06-01Aim. To investigate the diagnostic potential of cardiac fatty acid binding protein (cFABP) vs. cardiac troponins at the early stages of acute coronary syndrome (ACS), by comparing specificity and sensitivity of the qualitative assessment of their blood levels. Material and methods. The independent R...
Get full text
Article -
17
SPECTRAL ANALYSIS OF HEART RATE FLUCTUATIONS IN PATIENTS WITH ESSENTIAL HYPERTENSION by O. D. Ostroumova, V. I. Mamayev, M. V. Nesterova, I. A. Kuzmichev, A. I. Martynov
Published 2000-12-01Spectral analysis of heart rate fluctuations in patients with essential hypertension.
Get full text
Article -
18
SYSTOLIC BLOOD PRESSURE AS ONE OF THE FACTORS DECREASING AORTA TENSILITY IN ELDERLY PATIENTS WITH ESSENTIAL HYPERTENSION by A. I. Martynov, O. D. Ostorumova, T. S. Pustovitova, V. I. Mamaev, S. Y. Gedgafova, N. E. Sharkova, T. E. Rybkina
Published 2001-10-01Systolic blood pressure as one of the factors decreasing aorta tensility in elderly patients with essential hypertension.
Get full text
Article -
19
Improving arterial hypertension control in patients with high cardiovascular event risk: main stages of Russian Research and Clinical Program ARGUS-2 by A. I. Martynov, V. S. Moiseev, R. G. Oganov, Zh. D. Kobalava, Yu. V. Kotovskaya, E. G. Starostina
Published 2006-08-01Principal results of the Russian Research and Clinical Program ARGUS. In this patient group, arterial hypertension (AH) control is very low, as well as diuretic prescription rate. High AH-related hospitalization rate is an evidence of a need for studying AH in-patient management problem, clinical an...
Get full text
Article -
20
Modern views on acetylsalycilic acid in thrombosis/embolia prevention by A. I. Martynov, G. N. Gorochovskaya, N. G. Avetyan, E. V. Akatova, A. P. Kondrakhin, G. A. Romanovsakya
Published 2004-06-01.
Get full text
Article